Association of IL-33 in modeling type-2 airway inflammation and pulmonary emphysema in mice

Immun Inflamm Dis. 2024 Apr;12(4):e1252. doi: 10.1002/iid3.1252.

Abstract

We developed pulmonary emphysema and a type 2 airway inflammation overlap mouse model. The bronchoalveolar lavage (BAL) interleukin 13 (IL-13), IL-4, and IL-5 levels in the overlap model were higher than in the pulmonary emphysema model and lower than in the type 2 airway inflammation model, but IL-33 level in the lung was higher than in other models. IL-33 and interferon-γ (IFNγ) in lungs may control the severity of a type 2 airway inflammation in lung.

Keywords: COPD; IFNγ; IL‐13; IL‐33; IL‐4; IL‐5; asthma; innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid / immunology
  • Disease Models, Animal*
  • Inflammation / immunology
  • Inflammation / metabolism
  • Interferon-gamma / immunology
  • Interferon-gamma / metabolism
  • Interleukin-33* / metabolism
  • Lung / immunology
  • Lung / metabolism
  • Lung / pathology
  • Mice
  • Mice, Inbred C57BL
  • Pulmonary Emphysema* / etiology
  • Pulmonary Emphysema* / immunology
  • Pulmonary Emphysema* / metabolism
  • Pulmonary Emphysema* / pathology

Substances

  • Interleukin-33
  • Il33 protein, mouse
  • Interferon-gamma